These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27155682)

  • 1. [New guidelines and new therapy options in severe asthma].
    Einecke D
    MMW Fortschr Med; 2016 May; 158(9):18-9. PubMed ID: 27155682
    [No Abstract]   [Full Text] [Related]  

  • 2. Emerging Biologics in Severe Asthma.
    Pavord ID; Hilvering B; Shrimanker R
    Immunol Allergy Clin North Am; 2016 Aug; 36(3):609-23. PubMed ID: 27401629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reslizumab (Cinqair) for severe eosinophilic asthma.
    Med Lett Drugs Ther; 2016 Jun; 58(1497):81-2. PubMed ID: 27305070
    [No Abstract]   [Full Text] [Related]  

  • 4. Selection of Biologics in Severe Asthma: A Multifaceted Algorithm.
    Dávila I; Quirce S; Olaguibel JM
    J Investig Allergol Clin Immunol; 2019; 29(4):325-328. PubMed ID: 30969172
    [No Abstract]   [Full Text] [Related]  

  • 5. Unconventional treatment options in severe asthma: an overivew.
    Banh HL
    J Pharm Pharm Sci; 2011; 14(3):387-99. PubMed ID: 22202222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nearly uncontrollable hyperreactivity. Last options in bronchial asthma].
    Füesl HS; Stiefelhagen P
    MMW Fortschr Med; 2014 Mar; 156(5):17. PubMed ID: 24912253
    [No Abstract]   [Full Text] [Related]  

  • 7. [Severe refractory eosinophilic asthma].
    Jäger-Becker D
    MMW Fortschr Med; 2016 Feb; 158(3):67. PubMed ID: 27119709
    [No Abstract]   [Full Text] [Related]  

  • 8. Biologic Targeting: New and Effective Therapeutic Approaches against Severe Asthma.
    Yang X; Feng HR; Chen ZM; Ying SM
    Chin Med J (Engl); 2018 May; 131(9):1009-1012. PubMed ID: 29692369
    [No Abstract]   [Full Text] [Related]  

  • 9. Are biological drugs effective and safe in older severe asthmatics?
    Benfante A; Principe S; Battaglia S; Scichilone N
    Expert Opin Drug Saf; 2019 May; 18(5):369-380. PubMed ID: 30983432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe T2-high asthma in the biologics era: European experts' opinion.
    Pavord I; Bahmer T; Braido F; Cosío BG; Humbert M; Idzko M; Adamek L
    Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31285291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy goal is asthma control].
    Stiefelhagen P
    MMW Fortschr Med; 2016 Apr; 158(7):20. PubMed ID: 27071566
    [No Abstract]   [Full Text] [Related]  

  • 12. High blood eosinophil counts predict sputum eosinophilia in patients with severe asthma.
    Fowler SJ; Tavernier G; Niven R
    J Allergy Clin Immunol; 2015 Mar; 135(3):822-4.e2. PubMed ID: 25445828
    [No Abstract]   [Full Text] [Related]  

  • 13. Biologics, Clinical Context, and the Asthmas.
    Casale TB; Israel E
    J Allergy Clin Immunol Pract; 2019; 7(5):1437-1439. PubMed ID: 31076059
    [No Abstract]   [Full Text] [Related]  

  • 14. Biologics in severe asthma: Which one, When and Where?
    Rupani H; Murphy A; Bluer K; Renwick C; McQuitty P; Jackson DJ; Heaney LG; Chaudhuri R; Menzies-Gow A; Calvert J; Siddiqui S
    Clin Exp Allergy; 2021 Sep; 51(9):1225-1228. PubMed ID: 34289191
    [No Abstract]   [Full Text] [Related]  

  • 15. Underestimating asthma severity--variability of classifications and outcomes.
    O'Connor RD
    Manag Care; 2004 Jul; 13(7 Suppl Reversing Asthma):3-8; discussion 17-9. PubMed ID: 18567140
    [No Abstract]   [Full Text] [Related]  

  • 16. Pediatric Severe Asthma in the Era of Biologic Treatments.
    Teague WG
    Pediatr Allergy Immunol Pulmonol; 2020 Sep; 33(3):118-120. PubMed ID: 32953228
    [No Abstract]   [Full Text] [Related]  

  • 17. Personalized medicine with biologics for severe type 2 asthma: current status and future prospects.
    Godar M; Blanchetot C; de Haard H; Lambrecht BN; Brusselle G
    MAbs; 2018 Jan; 10(1):34-45. PubMed ID: 29035619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Development and Biologics in Asthma. A New Era.
    Doyle R
    Ann Am Thorac Soc; 2016 Mar; 13 Suppl 1():S83-4. PubMed ID: 27027958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologics for Asthma and Risk of Infection: Cause for Concern?
    Lopes JP; Desai M
    Immunol Allergy Clin North Am; 2019 Aug; 39(3):429-445. PubMed ID: 31284931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the response to asthma biological therapy.
    Roberts G
    Clin Exp Allergy; 2020 Sep; 50(9):992-993. PubMed ID: 32902035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.